Updated: January 29, 2026
Alternatives to Ezetimibe If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- Why You Might Need an Alternative to Ezetimibe
- Option 1: Statins (First-Line Alternative)
- Option 2: Bempedoic Acid (Nexletol)
- Option 3: PCSK9 Inhibitors (Repatha, Praluent)
- Option 4: Bile Acid Sequestrants (Cholestyramine, Colesevelam)
- What to Tell Your Doctor
- If It's Just a Temporary Supply Issue, Try medfinder First
Can't fill your ezetimibe prescription? Here are the most common alternatives your doctor may consider, including statins, PCSK9 inhibitors, and bempedoic acid.
Ezetimibe is a well-tolerated, widely available cholesterol-lowering drug — but there are situations where you might need an alternative. Maybe your pharmacy is out of stock, maybe you're experiencing side effects, or maybe your insurance has changed your coverage. Whatever the reason, it's important to know your options before simply stopping your medication.
Always talk to your doctor before switching or stopping ezetimibe. The alternatives described below vary in how they work, their side effect profiles, and their cost. What's right for you depends on your specific cholesterol levels, cardiovascular risk, and other medications.
Why You Might Need an Alternative to Ezetimibe
Pharmacy is out of stock and your prescription can't be filled in time
Side effects like diarrhea, joint pain, or liver enzyme elevations
Insurance no longer covers ezetimibe or prior authorization was denied
Your LDL is still too high on ezetimibe and you need something stronger
Option 1: Statins (First-Line Alternative)
If you're taking ezetimibe as monotherapy (without a statin), the most common alternative your doctor will consider is adding or switching to a statin. Statins are the gold-standard first-line therapy for high cholesterol and are generally more potent at lowering LDL than ezetimibe alone.
Rosuvastatin (Crestor): A high-potency statin that lowers LDL by 45-63%. Available as a generic at low cost. Often the first choice for patients needing significant LDL reduction.
Atorvastatin (Lipitor): The most commonly prescribed statin worldwide. Reduces LDL by 40-60%. Available as an inexpensive generic and taken once daily.
Simvastatin (Zocor): A moderate-potency statin. Less commonly started as new therapy today (higher doses carry myopathy risk), but still prescribed in combination with ezetimibe in Vytorin.
The main drawback: some patients experience muscle pain (myalgia) with statins, which is part of why ezetimibe is prescribed in the first place. If you can't tolerate statins, the options below may be appropriate.
Option 2: Bempedoic Acid (Nexletol)
Bempedoic acid (brand: Nexletol) is an oral non-statin cholesterol-lowering drug approved by the FDA in 2020. It works by blocking an enzyme in the liver called ATP citrate lyase, which is upstream of the cholesterol synthesis pathway. Because it only becomes active in the liver (unlike statins, which also affect muscle), it's significantly less likely to cause muscle pain.
Bempedoic acid lowers LDL by about 15-25% as monotherapy. It also comes in a combination pill with ezetimibe called Nexlizet — so if you're already taking ezetimibe and need more LDL reduction without a statin, Nexlizet might let you simplify to one pill. However, Nexlizet is currently brand-only and can be expensive without good insurance coverage.
Option 3: PCSK9 Inhibitors (Repatha, Praluent)
PCSK9 inhibitors — evolocumab (Repatha) and alirocumab (Praluent) — are highly potent injectable cholesterol drugs that can lower LDL by 45-60%. They're typically reserved for patients at very high cardiovascular risk who haven't reached their LDL goal on statins plus ezetimibe.
PCSK9 inhibitors require a subcutaneous injection every 2-4 weeks (or every 6 months for inclisiran/Leqvio). They're very well tolerated, but prior authorization from insurance is nearly always required, and out-of-pocket costs without coverage can be extremely high.
Option 4: Bile Acid Sequestrants (Cholestyramine, Colesevelam)
Bile acid sequestrants like cholestyramine (Questran) and colesevelam (Welchol) are older cholesterol-lowering drugs that work in the intestine, similar to ezetimibe. They bind to bile acids, preventing cholesterol reabsorption. They lower LDL by about 10-25% and have no systemic absorption, making them very safe.
The downside: they're taken as powders (cholestyramine) or large tablets (colesevelam) several times a day, can cause constipation and bloating, and interfere with absorption of many other drugs. They're less convenient than ezetimibe's once-daily pill.
What to Tell Your Doctor
When discussing alternatives with your doctor, bring the following information:
Why you need an alternative (supply issue, side effects, cost, or insufficient LDL reduction)
Your current LDL level and your target (typically <70 mg/dL for high-risk patients, <100 mg/dL for moderate risk)
Any previous statin trials and whether they caused side effects
Your insurance coverage — prior authorization requirements differ by drug
If It's Just a Temporary Supply Issue, Try medfinder First
If you can't find ezetimibe because your pharmacy is out of stock, a prescription change may not be necessary. medfinder can call pharmacies near you to find which ones currently have ezetimibe in stock, so you can fill your prescription today without waiting for a reorder or making a prescription switch.
For more details on why ezetimibe can be temporarily hard to find, read Why is ezetimibe so hard to find?.
Frequently Asked Questions
The best alternative depends on your situation. If you can tolerate statins, rosuvastatin (Crestor) or atorvastatin (Lipitor) are more potent LDL-lowering options. If you have statin intolerance, bempedoic acid (Nexletol) is an oral alternative with a lower risk of muscle side effects. For very high-risk patients, PCSK9 inhibitors like evolocumab (Repatha) are the most powerful option. Always consult your doctor.
You shouldn't stop ezetimibe abruptly without speaking to your doctor, especially if you're taking it for secondary prevention (after a heart attack or stroke). Ezetimibe has a long half-life (~22 hours), so missing 1-2 doses won't cause immediate harm, but prolonged gaps in treatment can allow LDL to rise. Contact your doctor or use medfinder to locate it at another pharmacy.
Bempedoic acid (Nexletol) is a reasonable alternative for patients who cannot take statins, but it lowers LDL by about 15-25%, which is similar to ezetimibe monotherapy. The combination drug Nexlizet includes both bempedoic acid and ezetimibe in one pill — so it's more of an addition than a replacement. Discuss with your doctor whether Nexletol or Nexlizet fits your treatment goals.
PCSK9 inhibitors (Repatha, Praluent) are usually covered by insurance for patients with familial hypercholesterolemia or established cardiovascular disease who haven't met LDL goals on maximal statin plus ezetimibe. Prior authorization is almost always required. Without insurance, these drugs can cost $500+ per month, though manufacturer savings programs may significantly reduce the cost.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Ezetimibe also looked for:
More about Ezetimibe
30,080 have already found their meds with Medfinder.
Start your search today.





